Integration of Novel Diagnostics into Clinical Practice
April Rieger2023-11-15T12:51:08-05:00June 29th, 2015|Categories: Blog, HEOR Feature|Tags: Avalon Health Economics, biomarkers, Cara Scheibling, clinical practice guidelines, Companion diagnostics, economic value, health services research, John Schneider, pharmaceuticals, specialty pharmaceuticals, tHEORetically Speaking|
By John Schneider, Ph.D Similar to drug and device markets, a critical part of the success of novel [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Press Release
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication